Glaxo Group Limited

Glaxosmithkline Intellectual Property Development Limited

Smithkline Beecham Corporation

Paul Spencer Jones

Julie Nicole Hamblin

Joelle Le

Suzanne Elaine Keeling

Nigel James Parr

Charlotte Jane Mitchell

Keith Biggadike

Jeremy John Payne

Robert David Willacy

Mika Lindvall

Alison Judith Redgrave

Martin Redpath Johnson

Caroline Mary Cook

Christopher David Edlin

Diane Mary Coe

Anthony William James Cooper

Christopher James Lunniss

John Edward Robinson

Siegfried B Christensen, Iv

Gordon H Phillipps

Michael D Dowle

Timothy John Ritchie

Colin David Eldred

Stephen Barry Guntrip

Michael David Barker

Brian Evans

Katherine Louise Jones

Naimisha Trivedi

David George Allen

Ian Robert Baldwin

Simon Gaines

Kenneth David Down

Paul Faulder

Juliet Kay Simpson

Christian Alan Paul Smethurst

Michael David Woodrow

Lionel Trottet

Stuart Holman

Yoshiaki Washio

Anthony William Dean

Amyn Pyarali Sayani

Sharon Lisa Gough

Mika Kristian Lindvall

Tracy Jane Redfern

Martin E Cooper

Zoe Alicia Harrison

The invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Compounds

The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.

Polymorphs and salts

The present invention is directed to compounds for use in the treatment or prevention of influenza virus infection.

Indazole derivatives for use in the treatment of influenza virus infection

The present invention is directed to a polymorph of a compound and salts of a compound and polymorphs thereof, which compound is an inhibitor of kinase activity. 

[object Object]

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases

The invention provides 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide, which is the compound of formula (I): or a salt thereof.

Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor

Growing community of inventors

Stevenage, United Kingdom

Paul Spencer Jones